Australia markets open in 5 hours 6 minutes

Almonty Industries Inc (1MR.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.7360-0.0040 (-0.54%)
As of 12:16PM CET. Market open.
Full screen
Previous close0.7400
Bid0.7300 x 1000000
Ask0.7680 x 1000000
Day's range0.7360 - 0.7400
52-week range0.3955 - 0.7540
Avg. volume1,475
Market cap73.576M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings date28 Mar 2023 - 03 Apr 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Successful Placement of CDI’s Raises A$2.0 Million

    TORONTO, January 25, 2023--Almonty Industries Inc. ("Almonty" or the "Company") (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) is pleased to announce that the Company has received firm commitments, primarily from existing Australian institutional investors who requested to increase their stake in the Company, to raise gross proceeds of A$2.0 million via the issue of 2.5 million Chess Depository Interests ("CDIs") at A$0.80 per CDI ("Placement").

  • Business Wire

    Third Sangdong Loan Facility Drawdown & Project Update

    TORONTO, November 15, 2022--Almonty Industries Inc. ("Almonty" or "the Company") (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI), is pleased to announce it has completed its third scheduled drawdown of the total US$75.1 million KfW IPEX-Bank project finance facility for its Sangdong Tungsten Mine (the Loan Facility), and to provide a project update from the Chairman of the Company.

  • Business Wire

    Almonty Announces the Filing of Its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Three and Nine Months Ended September 30, 2022 and Another Quarter of Positive EBITDA From Mining Operations(1).

    TORONTO, November 15, 2022--Almonty Industries Inc. ("Almonty" or the "Company") (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) today announced the filing of its unaudited interim condensed consolidated financial statements and management’s discussion & analysis ("MD&A") for the three and nine months ended September 30, 2022. Unless otherwise indicated, all currency amounts contained in this news release are expressed in Canadian dollars.